UBIGENE

ACHN-CAS9

banner

Red cotton OmniCell bank

10000+
Gene Knockout Cell Lines
2000+
Luc/EGFP/Cas9 Tool Cell Lines
1000+
Wild-type Cell Lines
ACHN-CAS9
Copy Product Info
Catalog#
YC-C087-Cas9-H
Size
1*10^6 Cells/vial (frozen vial)
Culture method
90%DMEM+10% FBS
Price(USD)
$2090
Instruction
-
STR Report

Overview

The Cas9 nuclease has been stably integrated into the host cell genome via genetic engineering methods, enabling stable, long-term expression of Cas9 protein. Cas9 stable cell lines serve as essential tools for CRISPR gene knockout, CRISPR library screening, and functional genomics studies. Ubigene has developed more than 500 Cas9 stable cell lines covering commonly used cell types. Gene knockout can be rapidly achieved by simply transfecting gRNA. Co-transfection of gRNA with donor DNA further enables gene knock-in or precise point mutations.

The Ubigene RKO-Cas9 cell line was generated using a lentiviral method and selected with antibiotics to achieve stable, high-level Cas9 expression. The RKO-CAS9 cell line has undergone functional editing validation, with results demonstrating that introduction of target gene gRNA can produce efficient DNA cleavage and indels, making it suitable for gene knockout, gRNA efficiency validation, or high-throughput CRISPR library screening in RKO cells.

Detailed Product Information

ACHN-CAS9
Product name
ACHN-CAS9
Expression gene
Cas9
Catalog number
YC-C087-Cas9-H
Resistance gene
hygro
Product category
Cas9 Stable Cell Lines
Mycoplasma test
Negative
Species
Human
Culture method
90%DMEM+10% FBS
Cell morphology
Epithelial-like,adherent
Storage condition
Liquid nitrogen
Shipping condition
Frozen vials; dry-ice package
Intended use
For research use only. Not intended for human or animal clinical trials, therapeutic or diagnostic use.
Passage ratio
1:2~1:3
Accession
-
Background

The ACHN cell line was initiated in November, 1979 from the malignant pleural effusion of a 22-year-old Caucasian male with widely metastatic renal adenocarcinoma (autopsy confirmed). Cells were seeded directly to culture flasks in Eagle's MEM with 10% FBS, then maintained and passaged 150 days in flasks. Cells were then inoculated subcutaneously into nude mice. After 4 weeks, palpable, locally invasive tumors were noted. Both the original cells (ACHN) and those recovered from nude mouse tumors were growth-inhibited by human interferons.

Product Advantages

Easy to use
Easy to use

Cas9 cell lines in our cell bank can stably express Cas9 protein. Each Cas9 Stable Cell Line is easy to use and enables gene knockout simply by transfecting gRNA, while transfection of gRNA and donor DNA results in gene knock-in or point mutations

High-efficient KO
High-efficient KO

These Cas9 stable cell lines have been used to construct the KO cell lines for various genes, gene KO efficiency 5-10 times improved.

Curated cells
Curated cells

Selected cells, low passages, good cell condition, high activity, applicable for all kinds of gene-editing experiments.

Plasmid Backbone Map

Plasmid Backbone Map

View Picture

Quality Control

1. Bacteria and fungi test
The test result was negative.
2. Mycoplasma test
The test result was negative.
3. STR Authentication

Intended use

For research use only. Not intended for human or animal clinical trials, therapeutic or diagnostic use

References

Related Popular Products

KO Cell Lines
PAGR1 Knockout cell line (ACHN)
Organism: Human
Gene Name: PAGR1
Gene ID: 79447
Size: 1*10^6
Catalog#: YKO-HA165032
More
MRPL45 Knockout cell line (ACHN)
Organism: Human
Gene Name: MRPL45
Gene ID: 84311
Size: 1*10^6
Catalog#: YKO-HA165031
More
MRM1 Knockout cell line (ACHN)
Organism: Human
Gene Name: MRM1
Gene ID: 79922
Size: 1*10^6
Catalog#: YKO-HA165030
More

Contact Us

Simply fill out the form below to leave your inquiry
— we will respond within 24 Hours

* Name

* Email

* Institution

* Products & Services of Interest

If email is not available, how else can we reach you?

How did you hear about us?

to-top
Logo
E-mail: info@ubigene.com
WhatsAPP: +86 153 6067 3248
TEL: +86 153 6067 3248(Int'l)
Copyright © 2025 Ubigene. All rights reserved.